145 related articles for article (PubMed ID: 9804691)
1. Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.
Shim JY; Collantes ER; Welsh WJ; Subramaniam B; Howlett AC; Eissenstat MA; Ward SJ
J Med Chem; 1998 Nov; 41(23):4521-32. PubMed ID: 9804691
[TBL] [Abstract][Full Text] [Related]
2. The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes.
Reggio PH; Basu-Dutt S; Barnett-Norris J; Castro MT; Hurst DP; Seltzman HH; Roche MJ; Gilliam AF; Thomas BF; Stevenson LA; Pertwee RG; Abood ME
J Med Chem; 1998 Dec; 41(26):5177-87. PubMed ID: 9857088
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs).
Dutta AK; Ryan W; Thomas BF; Singer M; Compton DR; Martin BR; Razdan RK
Bioorg Med Chem; 1997 Aug; 5(8):1591-600. PubMed ID: 9313864
[TBL] [Abstract][Full Text] [Related]
4. Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics.
Eissenstat MA; Bell MR; D'Ambra TE; Alexander EJ; Daum SJ; Ackerman JH; Gruett MD; Kumar V; Estep KG; Olefirowicz EM
J Med Chem; 1995 Aug; 38(16):3094-105. PubMed ID: 7636873
[TBL] [Abstract][Full Text] [Related]
5. Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.
Shim JY; Welsh WJ; Cartier E; Edwards JL; Howlett AC
J Med Chem; 2002 Mar; 45(7):1447-59. PubMed ID: 11906286
[TBL] [Abstract][Full Text] [Related]
6. Common cannabimimetic pharmacophoric requirements between aminoalkyl indoles and classical cannabinoids.
Xie XQ; Eissenstat M; Makriyannis A
Life Sci; 1995; 56(23-24):1963-70. PubMed ID: 7776820
[TBL] [Abstract][Full Text] [Related]
7. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles.
Jansen EM; Haycock DA; Ward SJ; Seybold VS
Brain Res; 1992 Mar; 575(1):93-102. PubMed ID: 1504787
[TBL] [Abstract][Full Text] [Related]
8. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding.
Aung MM; Griffin G; Huffman JW; Wu M; Keel C; Yang B; Showalter VM; Abood ME; Martin BR
Drug Alcohol Depend; 2000 Aug; 60(2):133-40. PubMed ID: 10940540
[TBL] [Abstract][Full Text] [Related]
9. Aminoalkylindoles (AAIs): a new route to the cannabinoid receptor?
Ward SJ; Baizman E; Bell M; Childers S; D'Ambra T; Eissenstat M; Estep K; Haycock D; Howlett A; Luttinger D
NIDA Res Monogr; 1990; 105():425-6. PubMed ID: 1908557
[No Abstract] [Full Text] [Related]
10. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
Kuster JE; Stevenson JI; Ward SJ; D'Ambra TE; Haycock DA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1352-63. PubMed ID: 8450470
[TBL] [Abstract][Full Text] [Related]
11. High-resolution NMR and computer modeling studies of the cannabimimetic aminoalkylindole prototype WIN-55212-2.
Xie XQ; Han XW; Chen JZ; Eissenstat M; Makriyannis A
J Med Chem; 1999 Oct; 42(20):4021-7. PubMed ID: 10514272
[TBL] [Abstract][Full Text] [Related]
12. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
Ross RA; Brockie HC; Stevenson LA; Murphy VL; Templeton F; Makriyannis A; Pertwee RG
Br J Pharmacol; 1999 Feb; 126(3):665-72. PubMed ID: 10188977
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of analogs of indole-based cannabimimetic agents.
Mazzoni O; Diurno MV; di Bosco AM; Novellino E; Grieco P; Esposito G; Bertamino A; Calignano A; Russo R
Chem Biol Drug Des; 2010 Jan; 75(1):106-14. PubMed ID: 19895505
[TBL] [Abstract][Full Text] [Related]
14. Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists.
Houston DB; Howlett AC
Cell Signal; 1998 Oct; 10(9):667-74. PubMed ID: 9794249
[TBL] [Abstract][Full Text] [Related]
15. Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
Stark S; Pacheco MA; Childers SR
Cell Mol Neurobiol; 1997 Oct; 17(5):483-93. PubMed ID: 9353590
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum.
Devlin MG; Christopoulos A
J Neurochem; 2002 Mar; 80(6):1095-102. PubMed ID: 11953460
[TBL] [Abstract][Full Text] [Related]
17. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
18. WIN55212-2 docking to the CB1 cannabinoid receptor and multiple pathways for conformational induction.
Shim JY; Howlett AC
J Chem Inf Model; 2006; 46(3):1286-300. PubMed ID: 16711748
[TBL] [Abstract][Full Text] [Related]
19. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
[TBL] [Abstract][Full Text] [Related]
20. The Spicy Story of Cannabimimetic Indoles.
Howlett AC; Thomas BF; Huffman JW
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
